ATCOR Licensing

As the world’s leading producer of medical devices for measuring arterial stiffness and central blood pressure waveforms, ATCOR is uniquely positioned to partner with select brands by strategically licensing our SphygmoCor® and wearable biometric parameters to enhance industry-leading medical and consumer devices.

From the initial request and needs assessment through product development, testing, and roll-out, ATCOR works closely with each partner to ensure that our technology seamlessly delivers top-quality results and a world-class user experience. Incorporating ATCOR’s SphygmoCor technology into your device adds an incomparable user benefit that will set your brand apart in the crowded marketplace.



ATCOR Licensing

As the world’s leading producer of medical devices for measuring arterial stiffness and central blood pressure waveforms, ATCOR is uniquely positioned to partner with select brands by strategically licensing our SphygmoCor® and wearable biometric parameters to enhance industry-leading medical and consumer devices.

From the initial request and needs assessment through product development, testing, and roll-out, ATCOR works closely with each partner to ensure that our technology seamlessly delivers top-quality results and a world-class user experience. Incorporating ATCOR’s SphygmoCor technology into your device adds an incomparable user benefit that will set your brand apart in the crowded marketplace.


TicWatch GTH Pro featuring Arty® Heart Health powered by ATCOR

Together with Mobvoi, a leading AI company focusing on advanced voice interaction and hardware-software integration, ATCOR has developed a new entry in the highly successful TicWatch line of smartwatches. The TicWatch GTH Pro features unique dual sensor technology that enables highly accurate insights into arterial and heart health powered by ATCOR.

With just the light touch of a finger on the side sensor, the TicWatch GTH Pro can measure a user’s arterial waveforms – pressure waves based on the strength of the pulse as blood flows through the body – with algorithms based on ATCOR’s proprietary SphygmoCor® technology.

 
Get in touch with us